Alzheimer's diagnosis advances face challenges in detection and accessibility

Advances in biomarkers, imaging techniques, digital tools, and artificial intelligence are transforming the approach to Alzheimer's disease. These innovations allow for earlier diagnosis, personalized therapeutic decisions, and closer patient monitoring. However, experts emphasize that healthcare systems must develop the necessary infrastructure and integrated circuits to ensure these advancements are accessible and do not create new inequalities in care.

In the United States, research from Yale University indicates a significant underreporting of dementia diagnoses. A study revealed that 67% of older Americans had not reported receiving a dementia diagnosis, a rate much higher than for conditions like diabetes or arthritis. Early signs of the disease, such as difficulties with recent memory, word-finding, or managing finances, are often mistaken for normal aging or overlooked by primary care physicians due to time constraints.